SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-013762
Filing Date
2024-04-29
Accepted
2024-04-29 17:23:15
Documents
14
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A omer20240424_def14a.htm DEF 14A 786809
2 cancelmosig.jpg GRAPHIC 4016
3 chair.jpg GRAPHIC 851
4 comp01.jpg GRAPHIC 34898
5 comp02.jpg GRAPHIC 31720
6 demopulossig.jpg GRAPHIC 2721
7 internet.jpg GRAPHIC 1655
8 logo.jpg GRAPHIC 7970
9 mail.jpg GRAPHIC 1544
10 member.jpg GRAPHIC 948
11 omer20240424_def14aimg020.jpg GRAPHIC 766
12 phone.jpg GRAPHIC 1388
13 proxy01.jpg GRAPHIC 112045
14 proxy02.jpg GRAPHIC 163726
  Complete submission text file 0001437749-24-013762.txt   1291076
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34475 | Film No.: 24892902
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)